All Stories

  1. Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401
  2. Immune Status of Cervical Lymph Nodes in Head and Neck Cancer—A Surgical Oncology Perspective
  3. The Immunology of DLBCL
  4. Stromal POSTN Enhances Motility of Both Cancer and Stromal Cells and Predicts Poor Survival in Colorectal Cancer
  5. Establishment of Mucoepidermoid Carcinoma Cell Lines from Surgical and Recurrence Biopsy Specimens
  6. Cytokeratin 5/6 expression in pT1 bladder cancer predicts intravesical recurrence in patients treated with bacillus Calmette–Guérin instillation
  7. A case of bilateral uveitis associated with seminoma/germinoma in thymus and pineal glands, two primary lesions
  8. Pathological and Molecular Features of Nodal Peripheral T-Cell Lymphomas
  9. Hodgkin Lymphoma: Biology and Differential Diagnostic Problem
  10. WHO 2022 landscape of papillary and chromophobe renal cell carcinoma
  11. Summary of the Clinical Practice Guidelines for Penile Cancer 2021 by the Japanese Urological Association
  12. Clinical significance of IDC‐P as predictive factor after intensity‐modulated radiation therapy
  13. An Introduction to the WHO 5 th Edition 2022 Classification of Testicular tumours
  14. Detection of perineural invasion in prostate needle biopsies with deep neural networks
  15. In Situ PD-L1 Expression in Oral Squamous Cell Carcinoma Is Induced by Heterogeneous Mechanisms among Patients
  16. Gastric Plexiform Fibromyxoma Resected Using Nonexposed Endoscopic Wall-Inversion Surgery: A Case Report
  17. The Complete Loss of p53 Expression Uniquely Predicts Worse Prognosis in Colorectal Cancer
  18. SPATA18 Expression Predicts Favorable Clinical Outcome in Colorectal Cancer
  19. TGFB1 mRNA expression is associated with poor prognosis and specific features of inflammation in ccRCC
  20. Histologic-Based Tumor-Associated Immune Cells Status in Clear Cell Renal Cell Carcinoma Correlates with Gene Signatures Related to Cancer Immunity and Clinical Outcomes
  21. Artificial intelligence for diagnosis and Gleason grading of prostate cancer: the PANDA challenge
  22. A Novel Treatment Strategy for Advanced Lacrimal Sac Carcinomas Confirmed by p16 Immunostaining
  23. Comparable survival outcome between acquired cystic disease associated renal cell carcinoma and clear cell carcinoma in patients with end-stage renal disease: a multi-institutional central pathology study
  24. Mucin‐producing urothelial‐type adenocarcinoma of the prostate diagnosed after robot‐assisted radical prostatectomy
  25. Correction to: Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
  26. Primary leiomyoma of the ureter: a case report
  27. Improving function of cytotoxic T‐lymphocytes by transforming growth factor‐β inhibitor in oral squamous cell carcinoma
  28. Presence of corpora amylacea among prostate cancer cells: an unrecognised feature of intraductal carcinoma of the prostate
  29. Primary cutaneous methotrexate-associated B-cell lymphoproliferative disorders other than EBV-positive mucocutaneous ulcer: clinical, pathological, and immunophenotypic features
  30. The emerging role of artificial intelligence in the reporting of prostate pathology
  31. Prognostic value of programmed death-ligand 1 status in Japanese patients with renal cell carcinoma
  32. Elevated expression of B7 homolog 4 is associated with disease progression in upper urinary tract urothelial carcinoma
  33. Re: Editorial Comment on Intraoperative pathology consultation during urological surgery: Impact on final margin status and pitfalls of frozen section diagnosis
  34. Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis
  35. Artificial Intelligence for Diagnosis and Gleason Grading of Prostate Cancer in Biopsies—Current Status and Next Steps
  36. A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven
  37. Bronchial carcinoid tumor managed with bronchial artery embolization before endobronchial resection: A case report
  38. Cribriform prostate cancer: Morphologic criteria enabling a diagnosis, based on survey of experts
  39. ISUP Consensus Definition of Cribriform Pattern Prostate Cancer
  40. The Positivity of Phosphorylated STAT3 Is a Novel Marker for Favorable Prognosis in Germinal Center B-Cell Type of Diffuse Large B-Cell Lymphoma
  41. Primary Testicular Neuroendocrine Tumor Coexisting With Seminoma Sharing Germ Cell Origin
  42. Expression and Prognostic Significance of CD47–SIRPA Macrophage Checkpoint Molecules in Colorectal Cancer
  43. Bladder preservation therapy in combination with atezolizumab and radiation therapy for invasive bladder cancer (BPT-ART) – A study protocol for an open-label, phase II, multicenter study
  44. Artificial intelligence assistance significantly improves Gleason grading of prostate biopsies by pathologists
  45. Editorial Comment to Prognostic significance of tertiary Gleason pattern in the contemporary era of Gleason grade grouping: A narrative review
  46. High phospho‐histone H3 expression uniquely predicts favorable survival among four markers of cellular proliferation in colorectal cancer
  47. Interobserver reproducibility of perineural invasion of prostatic adenocarcinoma in needle biopsies
  48. Prevalence and Clinicopathologic Features of Intestinal Perforation Caused by Segmental Absence of the Intestinal Musculature in Adults
  49. pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients’ prognostic accuracy
  50. Increased expression of adenosine 2A receptors in metastatic renal cell carcinoma is associated with poorer response to anti-vascular endothelial growth factor agents and anti-PD-1/Anti-CTLA4 antibodies and shorter survival
  51. Association of Matrix Metalloproteinase‐2 mRNA Expression with Subtypes of Pediatric Cholesteatoma
  52. Benign mimics of prostate cancer
  53. Grade group 2 (10% ≥ GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate
  54. Loss-of-function mutation of c-Ret causes cerebellar hypoplasia in mice with Hirschsprung disease and Down's syndrome
  55. Urothelial carcinoma: variant histology, molecular subtyping, and immunophenotyping significant for treatment outcomes
  56. Intraductal carcinoma of the prostate is not a diagnostic entity
  57. Thyroid Gland Flap for Minimally Invasive Reconstructive Head and Neck Surgery
  58. Prostate cancer grading, time to go back to the future
  59. Nodal EBV-positive polymorphic B cell lymphoproliferative disorder with plasma cell differentiation: clinicopathological analysis of five cases
  60. Synchronous clear cell renal cell carcinoma and clonal plasmacytoid cell infiltration: A case report and literature review
  61. An Elderly Case of Lung Adenocarcinoma with an Epidermal Growth Factor Receptor Gene L861Q Mutation Which Was Successfully Treated with Osimertinib
  62. The highest Fuhrman and WHO/ISUP grade influences the Ki‐67 labeling index of those of grades 1 and 2 in clear cell renal cell carcinoma
  63. Pathological and Virological Studies of p16-Positive Oropharyngeal Carcinoma with a Good Response to Neoadjuvant Chemotherapy
  64. UroVysion® predicts intravesical recurrence after radical nephroureterectomy for urothelial carcinoma of the upper urinary tract: a prospective study
  65. The clinical benefit of sequential therapy with androgen receptor axis‐targeted agents alone in patients with castration‐resistant prostate cancer: A propensity score‐matched comparison study
  66. Clinicopathological analysis of neoplastic PD-L1-positive EBV+ diffuse large B cell lymphoma, not otherwise specified, in a Japanese cohort
  67. Surgical outcomes of parathyroidectomy for secondary hyperparathyroidism resistant to calcimimetic treatment: A retrospective single‐center cohort study
  68. Enhanced PD‐L1 expression on tumor cells in primary cutaneous large T‐cell lymphoma with CD30 expression as classic Hodgkin lymphoma mimics: A report of lymph node lesions of two cases
  69. Prognostic significance of p16 expression in high‐grade prostate adenocarcinoma
  70. Editorial Comment from Dr Tsuzuki to Molecular characteristics and markers of advanced clear cell renal cell carcinoma: Pitfalls due to intratumoral heterogeneity and identification of genetic alterations associated with metastasis
  71. Effect of core needle biopsy number on intraductal carcinoma of the prostate (IDC-P) diagnosis in patients with metastatic hormone-sensitive prostate cancer
  72. Granular necrosis: a distinctive form of cell death in malignant tumours
  73. Thyroid gland flap minimizes mucosal defects at supracricoid partial laryngectomy with cricohyoidoepiglottopexy
  74. Common benign mimics of prostate cancer
  75. Clinical Practice Guidelines for Bladder Cancer 2019 update by the Japanese Urological Association: Summary of the revision
  76. Identification of areas of grading difficulties in prostate cancer and comparison with artificial intelligence assisted grading
  77. The 2019 International Society of Urological Pathology (ISUP) Consensus Conference on Grading of Prostatic Carcinoma
  78. Immune‐checkpoint molecules on regulatory T‐cells as a potential therapeutic target in head and neck squamous cell cancers
  79. Dataset for the reporting of urinary tract carcinoma—biopsy and transurethral resection specimen: recommendations from the International Collaboration on Cancer Reporting (ICCR)
  80. Endometrial cancer arising from adenomyosis: Case report and literature review of MRI findings
  81. Clinical Practice Guidelines for Bladder Cancer 2019 edition by the Japanese Urological Association: Revision working position paper
  82. Correction to: Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme
  83. Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study
  84. Intraductal carcinoma of the prostate is an aggressive form of invasive carcinoma and should be graded
  85. Importance of the neoadjuvant rectal (NAR) score to the outcome of neoadjuvant chemotherapy alone for locally advanced rectal cancer
  86. Dataset for the reporting of carcinoma of the bladder—cystectomy, cystoprostatectomy and diverticulectomy specimens: recommendations from the International Collaboration on Cancer Reporting (ICCR)
  87. Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review
  88. Annular Sarcoidosis with Geographic Appearance in a Patient with Systemic Sarcoidosis
  89. Propensity score‐matched comparison of docetaxel and androgen receptor axis‐targeted agents in patients with castration‐resistant intraductal carcinoma of the prostate
  90. Response of intraductal carcinoma of the prostate to androgen deprivation therapy predicts prostate cancer prognosis in radical prostatectomy patients
  91. Automated acquisition of explainable knowledge from unannotated histopathology images
  92. Histopathological evaluation of minor salivary gland papillary–cystic tumours: focus on genetic alterations in sialadenoma papilliferum and intraductal papillary mucinous neoplasm
  93. Multi-institutional re-evaluation of prognostic factors in chromophobe renal cell carcinoma: proposal of a novel two-tiered grading scheme
  94. Nivolumab for adjuvant treatment of desmoplastic malignant melanoma: A case report
  95. Illuminating Clues of Cancer Buried in Prostate MR Image: Deep Learning and Expert Approaches
  96. Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype
  97. Data Set for the Reporting of Carcinoma of the Renal Pelvis and Ureter—Nephroureterectomy and Ureterectomy Specimens
  98. Histological analysis of the skin of Abca1-deleted mice: A potential model for dry skin
  99. Clinical impact of segmental renal vein invasion on recurrence in patients with clinical T1 renal cell carcinoma undergoing partial nephrectomy
  100. Increased infiltration of CCR4‐positive regulatory T cells in prostate cancer tissue is associated with a poor prognosis
  101. Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementation
  102. Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases
  103. Rhabdomyosarcoma arising from retroperitoneal teratoma in an infantile neurofibromatosis type 1 patient
  104. Dataset for reporting of carcinoma of the urethra (in urethrectomy specimens): recommendations from the International Collaboration on Cancer Reporting (ICCR)
  105. Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma
  106. The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance
  107. Bicytopenia in Primary Lung Melanoma Treated with Nivolumab
  108. Small cell lung cancer and interstitial pneumonia associated with anti‐transcriptional intermediary factor‐1γ‐positive dermatomyositis
  109. The International Society of Urological Pathology Education web—a web-based system for training and testing of pathologists
  110. Automated acquisition of knowledge beyond pathologists
  111. Editorial comment on Evolution, controversies and the future of prostate cancer grading
  112. Diagnostic Utility of UroVysion Combined With Conventional Urinary Cytology for Urothelial Carcinoma of the Upper Urinary Tract
  113. EBV‐positive mucocutaneous ulcer arising in rheumatoid arthritis patients treated with methotrexate: Single center series of nine cases
  114. Integrating tertiary Gleason pattern 5 into the ISUP grading system improves prediction of biochemical recurrence in radical prostatectomy patients
  115. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study
  116. Case of primary central nervous system histiocytic sarcoma with prominent proliferation of histiocytic cells between the trabeculae of reactive glial cells
  117. Therapeutic efficacy of rituximab for the management of adult-onset steroid-dependent nephrotic syndrome: a retrospective study
  118. Renal tumors in end-stage renal disease: A comprehensive review
  119. Oral 5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence cystoscopy for non-muscle-invasive bladder cancer: A multicenter phase III study
  120. Granulomatous pigmented purpuric dermatosis containing Propionibacterium acnes
  121. Whole-exome sequencing demonstrates recurrent somatic copy number alterations and sporadic mutations in specialized stromal tumors of the prostate
  122. Utility of Pathology Imagebase for standardisation of prostate cancer grading
  123. Efficacy of docetaxel in castration-resistant prostate cancer patients with intraductal carcinoma of the prostate
  124. Ascending Aortic Aneurysm in a Child With Fibulin-4 Deficiency
  125. Cerebral Syphilitic Gumma Can Arise Within Months of Reinfection: A Case of Histologically Proven Treponema pallidum Strain Type 14b/f Infection With Human Immunodeficiency Virus Positivity
  126. A CASE WITH LATE RECURRENCE OF EXTRAGONADAL GERM CELL TUMOR
  127. Fulminant adenovirus hepatitis with adenovirus‐associated esophagitis complicating malignant lymphoma
  128. Germline polymorphism of interferon-lambda3 is clinically associated with progression of renal cell carcinoma
  129. Prognostic parameter for high risk prostate cancer patients at initial presentation
  130. Pathology Imagebase-a reference image database for standardization of pathology
  131. In reply to: letter to the editor entitled: primary pure lymphoepithelioma-like carcinoma of the ureter
  132. Lymphoepithelioma-like carcinoma of the upper urinary tract
  133. Reappraisal of Epstein–Barr virus (EBV) in diffuse large B‐cell lymphoma (DLBCL): comparative analysis between EBV‐positive and EBV‐negative DLBCL with EBV‐positive bystander cells
  134. Pathological background of subcortical hyperintensities on diffusion-weighted images in a case of neuronal intranuclear inclusion disease
  135. Incidence of intraductal carcinoma, multifocality and bilateral significant disease in radical prostatectomy specimens from Japan and United States
  136. Renal transplantation-related risk factors for the development of uterine adenomatoid tumors
  137. Seminoma accompanying mature teratoma in an infantile mediastinal region: A rare presentation of infantile germ cell tumors
  138. Spectrum of Cystic Epithelial Tumors of the Prostate
  139. The effects of bevacizumab on intestinal anastomotic healing in rabbits
  140. Pulmonary Neoplasms in Patients with Birt-Hogg-Dubé Syndrome: Histopathological Features and Genetic and Somatic Events
  141. Different biological effects of a constant dose for single UVB irradiation with different intensities and exposure times
  142. The presence of intraductal carcinoma of the prostate in needle biopsy is a significant prognostic factor for prostate cancer patients with distant metastasis at initial presentation
  143. A novel case presenting with an unusual ureteral diverticular lesion similar to adenomyomatous hyperplasia of the gallbladder
  144. Adenocarcinoma arising in urinary bladder endocervicosis
  145. A peripheral primitive neuroectodermal tumor in the larynx: A case report and literature review
  146. Transcription factor LSF (TFCP2) inhibits melanoma growth
  147. Diagnosis of “Poorly Formed Glands” Gleason Pattern 4 Prostatic Adenocarcinoma on Needle Biopsy
  148. Diagnosis of Gleason Pattern 5 Prostate Adenocarcinoma on Core Needle Biopsy
  149. Generalized infantile myofibromatosis with a monophasic primitive pattern
  150. Update for the practicing pathologist: The International Consultation On Urologic Disease-European association of urology consultation on bladder cancer
  151. Relationship of Pathologic Factors to Efficacy of Sorafenib Treatment in Patients With Metastatic Clear Cell Renal Cell Carcinoma
  152. Role of bevacizumab in neoadjuvant chemotherapy and its influence on microvessel density in rectal cancer
  153. A rare case of spontaneous necrosis of primary renal cell carcinoma
  154. Intraductal carcinoma of the prostate: A comprehensive and updated review
  155. Editorial Comment from Dr Tsuzuki to Reporting trends and prognostic significance of lymphovascular invasion in muscle-invasive urothelial carcinoma: A population-based study
  156. Actin-Binding Protein, Espin: A Novel Metastatic Regulator for Melanoma
  157. MRI and FDG-PET for Assessment of Response to Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
  158. Influence of Histologic Criteria and Confounding Factors in Staging Equivocal Cases for Microscopic Perivesical Tissue Invasion (pT3a)
  159. Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens
  160. Tyrosine kinase inhibitor-induced vasculopathy in clear cell renal cell carcinoma: an unrecognized antitumour mechanism
  161. Handling and Staging of Renal Cell Carcinoma
  162. Growth Pattern, an Important Pathologic Prognostic Parameter for Clear Cell Renal Cell Carcinoma
  163. Renal Tumors
  164. The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
  165. The International Society of Urological Pathology (ISUP) Grading System for Renal Cell Carcinoma and Other Prognostic Parameters
  166. Long-Term Remission After Multiple Relapses in an Elderly Patient With Lymphomatoid Granulomatosis After Rituximab and High-Dose Cytarabine Chemotherapy Without Stem-Cell Transplantation
  167. Two cases of primary ovarian neuroblastoma arising from mature cystic teratomas
  168. Stable renal engraftment in a patient following successful tandem autologous/reduced-intensity conditioning allogeneic transplantation for treatment of multiple myeloma with del(17p) that developed as a post-transplantation lymphoproliferative disease ...
  169. A CASE OF MULTIPLE LUNG METASTASES OF RENAL CELL CARCINOMA FAILING TO RESPOND TO INTERFERON-α (IFN-α) AND SUNITINIB BUT MARKEDLY RESPONDING TO EVEROLIMUS
  170. Exposure to low-dose barium by drinking water causes hearing loss in mice
  171. Watchful Waiting Versus Intravesical BCG Therapy for High-grade pT1 Bladder Cancer with pT0 Histology After Second Transurethral Resection: Japan Clinical Oncology Group Study JCOG1019
  172. Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification
  173. Re: Shahrokh F. Shariat, Richard Zigeuner, Michael Rink, et al. Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM ...
  174. Alpha methylacyl‐CoA racemase (AMACR) in prostate adenocarcinomas from Japanese patients: Is AMACR a “race”‐dependent marker?
  175. Partial impairment of c-Ret at tyrosine 1062 accelerates age-related hearing loss in mice
  176. A novel hairless mouse model for malignant melanoma
  177. Urachal Carcinomas of the Nonglandular type
  178. An autopsy case of pandemic (H1N1) 2009 influenza virus-associated encephalopathy
  179. Re: Yann Neuzillet, Xavier Tillou, Romain Mathieu, et al. Renal Cell Carcinoma (RCC) in Patients With End-Stage Renal Disease Exhibits Many Favourable Clinical, Pathologic, and Outcome Features Compared With RCC in the General Population. Eur Urol 2011...
  180. Partial Requirement of Endothelin Receptor B in Spiral Ganglion Neurons for Postnatal Development of Hearing
  181. ERG gene rearrangement status in prostate cancer detected by immunohistochemistry
  182. Analysis of glial cell line–derived neurotrophic factor–inducible zinc finger protein 1 expression in human diseased kidney
  183. The post‐operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases
  184. A Case of Tracheal Salivary Gland-type Adenocarcinoma Successfully Resected Under Extracorporeal Membrane Oxygenation
  185. Molecular and Immunohistologic Analyses Cannot Reliably Solve Diagnostic Variation of Flat Intraepithelial Lesions of the Urinary Bladder
  186. Renal cell carcinomas in haemodialysis patients: does haemodialysis duration influence pathological cell types and prognosis?
  187. c-Ret–mediated hearing loss in mice with Hirschsprung disease
  188. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type
  189. Removal of Autografted Parathyroid Tissue for Recurrent Renal Hyperparathyroidism in Hemodialysis Patients
  190. A Novel Mouse Model for De novo Melanoma
  191. CLINICOPATHOLOGICAL STUDY OF THE 1973 WHO CLASSIFICATION AND THE WHO/ISUP CLASSIFICATION IN pTa BLADDER CARCINOMA
  192. Incidence of Parathyroid Glands Located in Thymus in Patients with Renal Hyperparathyroidism
  193. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure
  194. Expression of Parafibromin in Distant Metastatic Parathyroid Tumors in Patients with Advanced Secondary Hyperparathyroidism Due to Chronic Kidney Disease
  195. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein–Barr virus-associated B-cell lymphoproliferative disorder
  196. A supernumerary parathyroid gland located in an unusual site, parapharyngeal space, in a patient with persistent renal hyperparathyroidism
  197. Protective Effect of Hyperpigmented Skin on UV-Mediated Cutaneous Cancer Development
  198. ERRATUM
  199. Nestin expression as a new marker in malignant peripheral nerve sheath tumors
  200. Recurrent Renal Hyperparathyroidism Caused by Parathyromatosis
  201. Novel Hairless RET-Transgenic Mouse Line with Melanocytic Nevi and Anagen Hair Follicles
  202. A Working Group Classification of Focal Prostate Atrophy Lesions
  203. Prostatic ductal adenocarcinoma mimicking villous adenoma of the urethra
  204. Hematopoietic stem cell transplantation for natural killer-cell lineage neoplasms
  205. A Case of Large Solitary Fibrous Tumor Originated from Retroperitoneum
  206. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
  207. Usefulness of epithelial membrane antigen (EMA) to discriminate between perineural invasion and perineural indentation in prostatic carcinoma
  208. Immunohistochemical study of chromogranin A in Stage D2 prostate cancer
  209. Pyogenic granuloma of the stomach successfully treated by endoscopic resection after transarterial embolization of the feeding artery
  210. Fibroepithelial Polyp of the Lower Urinary Tract in Adults
  211. PREDICTION OF EXTRAPROSTATIC EXTENSION IN THE NEUROVASCULAR BUNDLE BASED ON PROSTATE NEEDLE BIOPSY PATHOLOGY, SERUM PROSTATE SPECIFIC ANTIGEN AND DIGITAL RECTAL EXAMINATION
  212. RADICAL RETROPUBIC PROSTATECTOMY. HOW OFTEN DO EXPERIENCED SURGEONS HAVE POSITIVE SURGICAL MARGINS WHEN THERE IS EXTRAPROSTATIC EXTENSION IN THE REGION OF THE NEUROVASCULAR BUNDLE?
  213. A Case of Gastrointestinal Stromal Tumor with Internal Tandem Duplication in the 3?-Terminal of the KIT Juxtamembrane Domain
  214. ALK-1 Expression in Inflammatory Myofibroblastic Tumor of the Urinary Bladder
  215. Solitary fibrous tumor of the kidney originating from the renal capsule and fed by the renal capsular artery
  216. Positive proximal (bladder neck) margin at radical prostatectomy confers greater risk of biochemical progression
  217. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans
  218. Enterovesical fistula complication in B-cell-type lymphoma of the small intestine
  219. The Prognostic Significance of Tertiary Gleason Pattern 5 in Radical Prostatectomy Specimens
  220. c-Kit-Targeting Immunotherapy for Hereditary Melanoma in a Mouse Model
  221. Accuracy of gleason grading by practicing pathologists and the impact of education on improving agreement
  222. Neonatal Sudden Death Due to Legionella Pneumonia Associated with Water Birth in a Domestic Spa Bath
  223. Adrenal Pseudocyst Mimicking a Pheochromocytoma Found after a Traffic Accident.
  224. RET tyrosine kinase enhances hair growth in association with promotion of melanogenesis
  225. Malignant Granular Cell Tumor of the Chest Wall.
  226. Peripheral T/Natural killer-cell lymphoma involving the female genital tract: A clinicopathologic study of 5 cases
  227. Lymphomatous features of aggressive NK cell leukaemia/lymphoma with massive necrosis, haemophagocytosis and EB virus infection
  228. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma
  229. Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells
  230. A case of natural killer/T cell lymphoma of the subcutis resembling subcutaneous panniculitis‐like T cell lymphoma
  231. Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformation
  232. Broncho-bronchiolitis obliterans as a complication of bone marrow transplantation: a clinicopathological study of eight autopsy cases
  233. Nodular granulomatous phlebitis of the skin: a fourth type of tuberculid
  234. Primary adenocarcinoma of the renal pelvis with special reference to histochemical observations
  235. Detection of Ret Homodimers in MEN 2A-Associated Pheochromocytomas
  236. Synchronous Double Cancer, Thymic Small Cell Carcinoma and Breast Cancer; A Case Report.
  237. Host intestinal intraepithelial γδ T lymphocytes present during acute graft‐versus‐host disease in mice may contribute to the development of enteropathy
  238. Kinetics of intestinal intraepithelial lymphocytes during acute graft‐versus‐host disease in mice